THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242 | -16.6% | 144 | 0.0% | 0.00% | – |
| Q2 2023 | $1,490 | -4.6% | 144 | 0.0% | 0.00% | – |
| Q1 2023 | $1,562 | -3.3% | 144 | 0.0% | 0.00% | – |
| Q4 2022 | $1,616 | -19.2% | 144 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 144 | +63.6% | 0.00% | – |
| Q4 2021 | $0 | – | 88 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 88 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 88 | +57.1% | 0.00% | – |
| Q4 2020 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -50.0% | 56 | -64.1% | 0.00% | – |
| Q2 2018 | $4,000 | +100.0% | 156 | +178.6% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 56 | +55.6% | 0.00% | – |
| Q4 2017 | $2,000 | -99.0% | 36 | -99.4% | 0.00% | – |
| Q3 2016 | $210,000 | +54.4% | 5,800 | -3.2% | 0.00% | – |
| Q2 2016 | $136,000 | +23.6% | 5,992 | +3.3% | 0.00% | – |
| Q1 2016 | $110,000 | +14.6% | 5,800 | 0.0% | 0.00% | – |
| Q4 2015 | $96,000 | +50.0% | 5,800 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | -15.8% | 5,800 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | -24.0% | 5,800 | -0.3% | 0.00% | – |
| Q1 2015 | $100,000 | +16.3% | 5,815 | +0.3% | 0.00% | – |
| Q4 2014 | $86,000 | -68.1% | 5,800 | -50.4% | 0.00% | – |
| Q3 2014 | $270,000 | +2600.0% | 11,684 | +4014.1% | 0.00% | – |
| Q2 2014 | $10,000 | – | 284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |